Divisions of Pediatric Neurology,
Pediatric Hematology/Oncology, and.
Pediatrics. 2014 Sep;134(3):e889-93. doi: 10.1542/peds.2013-3029. Epub 2014 Aug 11.
Low-molecular-weight heparins, such as enoxaparin, are often used to treat thrombosis in infants. We present 4 infants with diffuse brain injury who developed cerebral venous sinus thrombosis or deep vein thrombosis and were treated with enoxaparin. These infants subsequently developed subdural hemorrhages, and enoxaparin was stopped. In 3 cases, the subdural hemorrhages were found on routine surveillance brain MRI, and in 1 case imaging was urgently obtained because of focal seizures. Two patients needed urgent neurosurgical intervention, and all subdural hemorrhages improved or resolved on follow-up imaging. Each infant developed severe neurologic deficits, probably from the coexisting diffuse brain injury rather than from the subdural hemorrhages themselves. The risk of intracranial hemorrhage from enoxaparin may be accentuated in patients with diffuse brain injury, and careful consideration should be given before treatment in this population.
低分子量肝素,如依诺肝素,常被用于治疗婴儿的血栓症。我们报告了 4 例因弥散性脑损伤而接受依诺肝素治疗后发生脑静脉窦血栓或深静脉血栓的婴儿。这些婴儿随后出现了硬膜下血肿,并停用了依诺肝素。其中 3 例在常规监测脑 MRI 时发现硬膜下血肿,1 例因局灶性癫痫发作而紧急进行影像学检查。2 例患者需要紧急神经外科干预,所有硬膜下血肿在随访影像学检查中均改善或消退。每个婴儿都出现了严重的神经功能缺损,可能是由于同时存在弥散性脑损伤,而不是硬膜下血肿本身所致。弥散性脑损伤的患者可能会因依诺肝素而增加颅内出血的风险,因此在该人群中治疗前应慎重考虑。